Undisclosed Conflicts of Interest by Physicians Creating the CDC Opioid Prescribing Guidelines: An Epilogue
Pallimed
NOVEMBER 29, 2022
The CDC’s reply was unusual in that it provided no responsive documents, but cited Chou’s public disclosure of his conflict of interest from the July 2021 Meeting of the CDC BSC-NCIPC and recusal from those proceedings (13). Dr. Kollas provided testimony at a 2004 Congressional Hearing on OxyContin.
Let's personalize your content